富血小板纤维蛋白在牙周组织再生中的研究进展

doi:10.13701/j.cnki.kqyxyj.2020.09.002

摘要/Abstract

摘要： 牙周组织再生一直是牙周炎治疗的难点与热点。富血小板纤维蛋白(platelet-rich fibrin, PRF)是同时包含细胞、生长因子、纤维蛋白生物支架的第二代自体血小板血浆制品。近年来,由于低离心力概念引导的制备程序使PRF的理化性质发生了一些改变,形成了一些新的分支。PRF在生物信号分子、生物支架及血供方面贴近理想的组织再生微环境体系,能够促进再血管化和组织愈合,并能与药物及细胞联合应用以促进牙周组织再生的发生。本文将就近年来PRF在牙周组织再生领域的研究进行综述。

关键词: 富血小板纤维蛋白, 牙周再生, 再血管化

Abstract: Periodontal tissue regeneration is always a difficult and hot point in the treatment of periodontitis. PRF is a second-generation autologous platelet plasma product containing cells, growth factors, and fibrin biological scaffolds. In recent years, the physical and chemical properties of PRF have changed due to LSCC guided preparation procedure, and some new branches have been formed. PRF is close to the ideal microenvironment system of tissue regeneration in terms of biological signaling molecules, biological scaffolds, and blood supply, which can promote the revascularization and tissue healing. PRF can be used in combination with drugs and cells to promote the occurrence of periodontal tissue regeneration. This paper will review the researches of PRF in periodontal tissue regeneration in recent years.

Key words: platelet-rich fibrin, periodontal regeneration, revascularization

孙涛, 和红兵. 富血小板纤维蛋白在牙周组织再生中的研究进展[J]. 口腔医学研究, 2020, 36(9): 808-810.

SUN Tao, HE Hongbing. Research Progress of PRF in Periodontal Regeneration[J]. Journal of Oral Science Research, 2020, 36(9): 808-810.

参考文献

[1] Miron RJ, Chai J, Zheng S, et al. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation [J]. J Biomed Mater Res A, 2019,107(10):2257-2271.
[2] Pan L, Yong Z, Yuk KS, et al. Growth factor release from lyophilized porcine platelet-rich plasma: quantitative analysis and implications for clinical applications [J]. Aesthetic Plast Surg, 2016, 40(1):157-163.
[3] Litvinov RI, Weisel JW. What is the biological and clinical relevance of fibrin? [J]. Semin Thromb Hemost, 2016,42(4):333-343.
[4] Choukroun J, Ghanaati S. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept [J]. Eur J Trauma Emerg Surg, 2018,44(1):87-95.
[5] Diomede F, D'Aurora M, Gugliandolo A, et al. Biofunctionalized scaffold in bone tissue repair [J]. Int J Mol Sci, 2018,19(4):1022.
[6] Ozer K, Colak O. Leucocyte- and platelet-rich fibrin as a rescue therapy for small-to-medium-sized complex wounds of the lower extremities [J]. Burns Trauma, 2019,7:11.
[7] Xu C, Lu W, Bian S, et al. Porous collagen scaffold reinforced with surfaced activated PLLA nanoparticles [J]. ScientificWorldJournal, 2012, 2012:695137.
[8] Kubesch A, Barbeck M, Al-Maawi S, et al. A low-speed centrifugation concept leads to cell accumulation and vascularization of solid platelet-rich fibrin: an experimental study in vivo [J]. Platelets, 2019, 30(3):329-340.
[9] Herrera-Vizcaíno C, Dohle E, Al-Maawi S, et al. Platelet-rich fibrin secretome induces three dimensional angiogenic activation in vitro [J]. Eur Cell Mater, 2019,37:250-264.
[10] Isobe K, Watanebe T, Kawabata H, et al. Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [J]. Int J Implant Dent, 2017,3(1):17.
[11] Martande SS, Kumari M, Pradeep AR, et al. Platelet-rich fibrin combined with 1.2% atorvastatin for treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial [J]. J Periodontol, 2016,87(9):1039-1046.
[12] Fujioka-Kobayashi M, Miron RJ, Hernandez M, et al. Optimized platelet-rich fibrin with the low-speed concept: growth factor release, biocompatibility, and cellular response [J]. J Periodontol, 2017, 88(1):112-121.
[13] Horimizu M, Kubota T, Kawase T, et al. Synergistic effects of the combined use of human-cultured periosteal sheets and platelet-rich fibrin on bone regeneration: An animal study [J]. Clin Exp Dent Res, 2017, 3(4):134-141.
[14] Kizilda A, Cicek Y, Arabaci T, et al. The effect of leukocyte-platelet-rich fibrin on bone morphogenetic protein-2 and insulin-like growth factor-1 levels in patients with chronic periodontitis: a randomized split mouth clinical trail [J]. Growth Factors, 2018,36(5-6):239-245.
[15] To M, Su CY, Hidaka K, et al. Effect of advanced platelet-rich fibrin on accelerating alveolar bone formation in dogs: a histological and immunofluorescence evaluation [J]. Anat Sci Int, 2019, 94(3):238-244.
[16] Yoon JS, Lee SH, Yoon HJ. The influence of platelet-rich fibrin on angiogenesis in guided bone regeneration using xenogenic bone substitutes: a study of rabbit cranial defects [J]. J Craniomaxillofac Surg, 2014, 42(7):1071-1077.
[17] Arabaci T, Kose O, Albayrak M, et al. Advantages of autologous platelet-rich fibrin membrane on gingival crevicular fluid growth factor levels and periodontal healing: a randomized split-mouth clinical study [J]. J Periodontol, 2017, 88(8):771-777.
[18] Yaprak E, Kasap M, Akpinar G, et al. Abundant proteins in platelet-rich fibrin and their potential contribution to wound healing: An explorative proteomics study and review of the literature [J]. J Dent Sci, 2018,13(4):386-95.
[19] Ghanaati S, Booms P, Orlowska A, et al. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells [J]. J Oral Implantol, 2014, 40(6):679-689.
[20] Steller D, Herbst N, Pries R, et al. Impact of incubation method on the release of growth factors in non-Ca²⁺-activated PRP, Ca²⁺-activated PRP, PRF and A-PRF [J]. J Craniomaxillofac Surg, 2019, 47(2):365-372.
[21] Miron RJ, Fujioka-Kobayashi M, Hernandez M, et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? [J]. Clin Oral Investig, 2017, 21(8):2619-2627.
[22] Patel GK, Gaekwad SS, Gujjari SK, et al. Platelet-rich fibrin in regeneration of intrabony defects: a randomized controlled trial [J]. J Periodontol, 2017, 88(11):1192-1199.
[23] Bajaj P, Agarwal E, Rao NS, et al. Autologous platelet-rich fibrin in the treatment of 3-wall intrabony defects in aggressive periodontitis: a randomized controlled clinical trial [J]. J Periodontol, 2017, 88(11):1186-1191.
[24] Chadwick JK, Mills MP, Mealey BL. Clinical and radiographic evaluation of demineralized freeze-dried bone allograft versus platelet-rich fibrin for the treatment of periodontal intrabony defects in humans [J]. J Periodontol, 2016, 87(11):1253-1260.
[25] Galav S, Chandrashekar KT, Mishra R, et al. Comparative evaluation of platelet-rich fibrin and autogenous bone graft for the treatment of infrabony defects in chronic periodontitis: Clinical, radiological, and surgical reentry [J]. Indian J Dent Res, 2016, 27(5):502-507.
[26] Agarwal A, Gupta ND, Jain A. Platelet rich fibrin combined with decalcified freeze-dried bone allograft for the treatment of human intrabony periodontal defects: a randomized split mouth clinical trail [J]. Acta Odontol Scand, 2016, 74(1):36-43.
[27] Li X, Zhang Y, Zhong K, et al. Study on the bone regeneration induced by advanced-platelet-rich fibrin and beta- tricalcium phosphate composite [J]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2019,33(2):177-184.
[28] Oncu E. The use of platelet-rich fibrin versus subepithelial connective tissue graft in treatment of multiple gingival recessions: A randomized clinical trial [J]. Int J Periodontics Restorative Dent, 2017,37(2):265-271.